Italy / Mandatory COVID-19 Vaccines for Healthcare Workers; Chiesi & Angelini’s AI Investments; Sputnik V Manufacturing
The latest from Italian pharma, including the government’s decision to make COVID-19 vaccines mandatory for all…
Top Stories
Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in Europe, and its potential to boost the continent’s push to catch up with the…
Turkey / The Impact Of Brexit On CE Certificates Issued By UK Notified Bodies
The shockwaves from the UK’s exit from the European Union have resounded across the continent, including in…
Singapore / Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading…
Russia / Biocad Ramps up Sputnik V Manufacturing; Unlicensed Remdesivir Generics; Chinese Vaccine Rejection
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing,…
France / Valneva: Small, but Poised for COVID-19 Vaccine Success
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
France / Top 10 Pharma Companies
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and…
In Conversation
Haijun Dong – CEO, BioDuro-Sundia
Dr Haijun Dong, recently appointed CEO of BioDuro-Sundia, shares his priorities for the newly merged entity, one of the largest Contract Research, Development and Manufacturing organizations (CRDMOs) in the world, his talent strategy, and the use of AI within the sector. BioDuro has very strong capabilities on the discovery side and has a significant presence in both China and…
Latest Reports
Focus on USA
US FDA Drug Approvals 2020
In 2020, the US FDA's Center for Drug Evaluation & Research (CDER) approved…
5 US Rare Disease Start-Ups to Watch
Following on from our profile on five of the most promising clinical-stage…
Novavax: From No-Hoper to COVID-19 Vaccine Saviour?
From almost being de-listed by the NASDAQ stock index in 2018 due to poor…
USA: 2 Things the Biden Administration can do Now to Lower…
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can…
Read more: USA >>
Focus on Switzerland
Ichnos CEO on Glenmark Legacy, Biotech Transformation &…
After an illustrious career in oncology R&D, contributing greatly to the…
Switzerland: A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine…
ISREC’s Susan Gasser: A “Hard-Nosed” Approach to…
After 15 years as director at the Friedrich Miescher Institute for Biomedical…
Swiss Pharma: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland…
Read more: Switzerland >>
Focus on Vaccines
Russia Pharma News: Biocad Ramps up Sputnik V Manufacturing;…
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik…
LatAm Pharma News: COVAX Rollout in Colombia; União Quimica…
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia,…
Novavax: From No-Hoper to COVID-19 Vaccine Saviour?
From almost being de-listed by the NASDAQ stock index in 2018 due to poor…
Valneva: Small, but Poised for COVID-19 Vaccine Success
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed…
Read more: Vaccines >>
Focus on MEA
MEA: Pfizer’s Saudi Transformation; Urgent Call for Arab…
The latest news from Middle East & North African pharma, including…
MEA Roundup: Turkey’s Pharma Debt; Saudi Market Rise; UAE…
A roundup of the latest from the Middle East & Africa region, including…
Saudi Arabia: SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey,…
5 Saudi Arabian Pharma Companies to Know
Following on from our list of the overall top 10 companies in the Saudi Arabian…
Read more: MEA >>
Focus on Singapore
Singapore Pharma Industry Snapshot 2020
Singapore is home to a wide range of biopharmaceutical company headquarters,…
Medtech’s Post-COVID Paradigm in APAC
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech…
Singapore Macroeconomic & Competitiveness Snapshot 2020
Singapore is far ahead of its Asia-Pacific peers in terms of GDP per person.…
HSA: APAC’s Regulatory Gold Standard
As the most important pharma hub in its region, and one of the most important…
Read more: Singapore >>
Focus on Europe
Europe: EMA Medicine Approvals 2020
The full list of medicines recommended for approval by the European Medicines…
Latvia: Striving to Catch Up to its Neighbours on Innovation…
Dr Valters Bolevics, director general of the Association of International…
Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for…
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that…
Read more: Europe >>
Focus on China
Top 10 Chinese Pharma Companies 2020
The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken…
Public Insurance Coverage for Rare Disease Patients in…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare…
China: Yangtze River Pharmaceutical Group (YRPG) in Profile
One of the largest domestic pharma companies in China (ranking number one from…
New Drug Approvals in China 2020
The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals…